7X8X
structural insights into Mycobacterium tuberculosis ClpP1P2 inhibition by Cediranib: implications for developing antimicrobial agents targeting Clp protease
D-alanine--D-alanine ligase - Paraburkholderia xenovorans LB400
Include CSM | ||
Advanced Search | Browse Annotations |
RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.
All questions and comments will receive a response in a timely manner.